Announcing a medical research study for advanced hereditary breast cancer.
Not just for you, for them.
Men and women aged 18 years or older who have advanced breast cancer due to a BRCA1 or BRCA2 gene mutation are invited to see if they may qualify for the Brocade Study. The purpose of this medical research study is to determine the safety and effectiveness of an investigational medication in combination with chemotherapy in patients with advanced hereditary breast cancer.
Each individual will be evaluated to determine his or her eligibility. Those who qualify will receive investigational medication or an inactive placebo, study-related medical exams, and lab tests at no charge. Compensation for time and travel may also be available.